BroMocriptine-13C-d3
- CAS No.
- Chemical Name:
- BroMocriptine-13C-d3
- Synonyms
- BroMocriptine-13C-d3
- CBNumber:
- CB42673660
- Molecular Formula:
- C32H37BrD3N5O5
- Molecular Weight:
- 658.621985334
- MDL Number:
- MOL File:
- Mol file
| Product description | Number | Pack Size | Price |
| Bromocriptine-13C-d3 | 26669 | 500μg | $413 |
| Bromocriptine-13C-d3 | 26669 | 1mg | $783 |
| BROMOCRIPTINE-13C-D3 95.00% | RDL0006691 | 5MG | $500.93 |
BroMocriptine-13C-d3 price More Price(3)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 26669 | Bromocriptine-13C-d3 | 500μg | $413 | 2024-03-01 | Buy | |
| Cayman Chemical | 26669 | Bromocriptine-13C-d3 | 1mg | $783 | 2024-03-01 | Buy | |
| American Custom Chemicals Corporation | RDL0006691 | BROMOCRIPTINE-13C-D3 95.00% | 5MG | $500.93 | 2021-12-16 | Buy |
BroMocriptine-13C-d3 Chemical Properties,Uses,Production
Description
Bromocriptine-13C-d3 is intended for use as an internal standard for the quantification of bromocriptine (Item No. 14598) by GC- or LC-MS. Bromocriptine is a dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM for dopamine D1, D2, D3, D4, and D5 receptors, respectively).1 It also binds to the serotonin (5-HT) receptor subtypes 5-HT1A and 5-HT1D (Kis = 12.9 and 10.7 nM, respectively), as well as α1-adrenergic receptors (Kis = 1.12-4.17 nM).1,2 Bromocriptine (5 mg/kg) restores locomotor activity, without inducing dyskinesia, in a macaque model of Parkinson’s disease induced by MPTP.3 Formulations containing bromocriptine have been used in the treatment of Parkinson's disease, hyperprolactinemia-associated dysfunctions, and acromegaly.WARNING This product is not for human or veterinary use.
References
[1] MSC TROND KVERNMO PhD E B PhD Sebastian Härtter. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists[J]. Clinical therapeutics, 2006, 28 8: Pages 1065-1078. DOI: 10.1016/j.clinthera.2006.08.004
[2] MARK J MILLAN. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.[J]. Journal of Pharmacology and Experimental Therapeutics, 2002, 303 2: 791-804. DOI: 10.1124/jpet.102.039867
[3] C. ROUILLARD T. D P P J Bédard. Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393[J]. European journal of pharmacology, 1990, 185 2: Pages 209-215. DOI: 10.1016/0014-2999(90)90642-j
BroMocriptine-13C-d3 Preparation Products And Raw materials
Raw materials
Preparation Products
BroMocriptine-13C-d3 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +17819995354 | marketing@targetmol.com | United States | 19961 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11218 | 58 |
| TLC Pharmaceutical Standards Ltd. | 18012923235; 18012923235 | chinasales04@tlcstandards.com.cn | China | 7975 | 58 |
| BePure (Beijing) Biotechnology Co. | 58896805 | 7993601name@qq.com | CHINA | 6620 | 58 |
| Cayman Chemical Company | 800-364-9897 | sales@caymanchem.com | China | 6838 | 58 |
View Lastest Price from BroMocriptine-13C-d3 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2025-08-21 | Bromocriptine-13C-d3 | US $0.00-0.00 / mg | 10g | TargetMol Chemicals Inc. |
-
- Bromocriptine-13C-d3
- US $0.00-0.00 / mg
- TargetMol Chemicals Inc.
(BroMocriptine-13C-d3)Related Search:
1of3
